kevin_tulsa — that is really helpful context on Oral GLP-1 pipeline. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
To answer KetoKyle's question specifically:
From a clinical standpoint, Oral GLP-1 pipeline overview is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
SteveThurs — wow. I've been looking for this exact info for weeks.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesAdding my data to this Oral GLP-1 pipeline discussion:
| Metric | Baseline | Month 5 | Month 6 |
|---|---|---|---|
| Weight | 264 lbs | 249 lbs | 209 lbs |
| A1C | 6.8% | 6.0% | 5.2% |
| hsCRP | 8.0 | 4.0 | 0.6 |
Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.
Slightly tangential to Oral GLP-1 pipeline but SteveThurs reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.